RUBIN PAUL D
SEC CIK 1210905 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BIOA | BioAge Labs, Inc. | Chief Medical Off | 8,820 | — | $1.46M | 12 | 2025-12-04 | 2026-04-01 |
Most active insiders at BIOA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fortney Kristen | CEO, Dir | — | $4.22M |
| 2 | Barton Shane | Principal Accounting Off | — | $1.58M |
| 3 | RUBIN PAUL D | Chief Medical Off | — | $1.46M |
| 4 | GOLDSTEIN DOV A MD | CFO | — | $531.8K |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-04-03 16:07 | 2026-04-01 | BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Off | M - OptEx | $5.05 | +8,820 | 8,820 | New | +$44.6K |
| DT | 2026-04-03 16:07 | 2026-04-01 | BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Off | S - Sale+OE | $17.81 | -8,820 | 0 | -100% | -$157.1K |
| DM | 2026-03-03 | 2026-03-02 | BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Off | M - OptEx | $4.77 | +7,433 | 5,433 | New | +$35.5K |
| D | 2026-03-03 | 2026-03-02 | BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Off | S - Sale+OE | $20.30 | -7,433 | 0 | -100% | -$150.9K |
| D | 2026-02-03 | 2026-02-02 | BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Off | S - Sale+OE | $18.75 | -7,433 | 0 | -100% | -$139.4K |
| DM | 2026-02-03 | 2026-02-02 | BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Off | M - OptEx | $4.77 | +7,433 | 5,433 | New | +$35.5K |
| D | 2026-01-06 | 2026-01-02 | BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Off | S - Sale+OE | $12.85 | -7,433 | 0 | -100% | -$95.5K |
| DM | 2026-01-06 | 2026-01-02 | BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Off | M - OptEx | $4.77 | +7,433 | 5,433 | New | +$35.5K |
| D | 2025-12-11 | 2025-12-09 | BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Off | S - Sale+OE | $12.00 | -18.0K | 0 | -100% | -$216.0K |
| D | 2025-12-11 | 2025-12-09 | BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Off | M - OptEx | $6.57 | +18.0K | 18.0K | New | +$118.3K |
| D | 2025-12-05 | 2025-12-04 | BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Off | M - OptEx | $4.11 | +68.9K | 68.9K | New | +$283.2K |
| D | 2025-12-05 | 2025-12-04 | BIOA | BioAge Labs, Inc. | RUBIN PAUL D | Chief Medical Off | S - Sale+OE | $10.19 | -68.9K | 0 | -100% | -$702.1K |
Purchase Sale Sale after option exercise All abbreviations